ClinVar Miner

Submissions for variant NM_024649.5(BBS1):c.1340-1G>T

dbSNP: rs1555049893
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000669016 SCV000793711 likely pathogenic Bardet-Biedl syndrome 1 2017-08-29 criteria provided, single submitter clinical testing
Baylor Genetics RCV000669016 SCV004217373 pathogenic Bardet-Biedl syndrome 1 2023-07-24 criteria provided, single submitter clinical testing
Invitae RCV003523008 SCV004291439 pathogenic Bardet-Biedl syndrome 2023-09-30 criteria provided, single submitter clinical testing Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 553542). Disruption of this splice site has been observed in individuals with clinical features of Bardet-Biedl syndrome (PMID: 34940782). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 13 of the BBS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in BBS1 are known to be pathogenic (PMID: 12118255, 21520335, 27032803). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.